Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Therapy-related Toxicity”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05923242
What this trial is testing

Translating ECHOS2 Into an mHealth Platform

Who this might be right for
Childhood CancerCardiac ToxicityPediatric Cancer
Washington University School of Medicine 73
Not applicableStudy completedNCT06817044
What this trial is testing

Optimising Screening for the Cardiotoxic Effects of Cancer Therapy

Who this might be right for
Ventricular DysfunctionCardiotoxicityChemotherapeutic Toxicity
Barts & The London NHS Trust 80
Not applicableEnrolling By InvitationNCT07499128
What this trial is testing

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

Who this might be right for
Cytokine Release SyndromeNeoplasmsLymphoma+13 more
National Cancer Institute (NCI) 136
Not applicableEnrolling By InvitationNCT06840652
What this trial is testing

Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption

Who this might be right for
Alcoholic CirrhosisAlcohol AbstinenceAlcohol Withdrawal+2 more
Corporacion Parc Tauli 120
Large-scale testing (Phase 3)UnknownNCT01216800
What this trial is testing

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

Who this might be right for
Head and Neck CancerOtotoxicityRadiation Toxicity
Institute of Cancer Research, United Kingdom 84
Not applicableStudy completedNCT02794636
What this trial is testing

Interferon Toxicities in Melanoma Treatment

Who this might be right for
Stage III Melanoma
Bristol-Myers Squibb 436
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Not applicableUnknownNCT06549621
What this trial is testing

Cardiotoxicity of Carbon Monoxide in Patients Treated With Hyperbaric Oxygen Therapy

Who this might be right for
Carbon Monoxide Poisoning
University Hospital, Brest 66
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Not applicableActive Not RecruitingNCT04305613
What this trial is testing

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation Therapy

Who this might be right for
CardiotoxicityLung Cancer Stage IIILung Cancer Stage II+1 more
Abramson Cancer Center at Penn Medicine 221
Not applicableNot Yet RecruitingNCT07008027
What this trial is testing

Real World Asparaginase Therapy Toxicity

Who this might be right for
Drug Toxicity
St. Jude Children's Research Hospital 200
Large-scale testing (Phase 3)Study completedNCT00024427
What this trial is testing

Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganPancreatic Cancer
Wellstat Therapeutics 250
Testing effectiveness (Phase 2)Ended earlyNCT05022797
What this trial is testing

Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS

Who this might be right for
Diffuse Large B-Cell LymphomaDrug Toxicity
Fundacion CRIS de Investigación para Vencer el Cáncer 3
Testing effectiveness (Phase 2)Study completedNCT01548690
What this trial is testing

Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury

Who this might be right for
Acute Liver FailureAcute Liver Injury
William Lee 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT06399029
What this trial is testing

Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities

Who this might be right for
ExanthemaLichenoid Skin Rashes Under Anti-PD1 Tumor Therapy
University of Zurich 22
Not applicableLooking for participantsNCT01993498
What this trial is testing

Chronic Toxicities Related to Treatment in Patients With Localized Cancer

Who this might be right for
Breast Cancer Nos Metastatic RecurrentEarly Lung Cancer
UNICANCER 14,750
Testing effectiveness (Phase 2)Study completedNCT00003089
What this trial is testing

Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganLung Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Post-approval studies (Phase 4)Study completedNCT03667157
What this trial is testing

Liver Function After Intravenous Methylprednisolone Administration

Who this might be right for
Graves DiseaseGraves OphthalmopathyLiver Diseases+11 more
Medical University of Warsaw 68
Not applicableUnknownNCT01285674
What this trial is testing

Intratympanic Steroid Treatment For The Prevention Of Inner Ear Toxicity Associated With Systemic Treatment With Cisplatin.

Who this might be right for
CisplatinOtotoxicityIntratympanic Steroids
Ziv Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT00372723
What this trial is testing

Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)

Who this might be right for
Toxic Epidermal Necrolysis
Loyola University
Next Page